Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
Highly Specialised Service for Severe, Complex and Atypical OI Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
J Med Genet. 2018 Mar;55(3):158-165. doi: 10.1136/jmedgenet-2017-104899. Epub 2017 Dec 20.
Cole-Carpenter syndrome (CCS) is commonly classified as a rare Osteogenesis Imperfecta (OI) disorder. This was following the description of two unrelated patients with very similar phenotypes who were subsequently shown to have a heterozygous missense mutation in .
Here, we report a 3-year old female patient with severe OI who on exome sequencing was found to carry the same missense mutation in as reported in the original cohort. We discuss the genetic heterogeneity of CCS and underlying mechanism of P4HB in collagen production.
We undertook detailed clinical, radiological and molecular phenotyping in addition, to analysis of collagen in cultured fibroblasts and electron microscopic examination in the patient reported here.
The clinical phenotype appears consistent in patients reported so far but interestingly, there also appears to be a definitive phenotypic clue (crumpling metadiaphyseal fractures of the long tubular bones with metaphyseal sclerosis which are findings that are uncommon in OI) to the underlying genotype ( variant).
(Prolyl 4-hydroxylase, betasubunit) encodes for PDI (Protein Disulfide isomerase) and in cells, in its tetrameric form, catalyses formation of 4-hydroxyproline in collagen. The recurrent variant in , c.1178A>G, p.Tyr393Cys, sits in the C-terminal reactive centre and is said to interfere with disulphide isomerase function of the C-terminal reactive centre. P4HB catalyses the hydroxylation of proline residues within the X-Pro-Gly repeats in the procollagen helical domain. Given the inter-dependence of extracellular matrix (ECM) components in assembly of a functional matrix, our data suggest that it is the organisation and assembly of the functional ECM that is perturbed rather than the secretion of collagen type I per se.
We provide additional evidence of as a cause of a specific form of OI-CCS and expand on response to treatment with bisphosphonates in this rare disorder.
Cole-Carpenter 综合征(CCS)通常被归类为罕见的成骨不全症(OI)疾病。这是在描述两名无关联的具有非常相似表型的患者之后得出的,他们随后被发现. 中的杂合错义突变。
本研究报告了一名 3 岁女性 OI 患者,通过外显子组测序发现她携带与原始队列中报道的相同的. 错义突变。我们讨论了 CCS 的遗传异质性和 P4HB 在胶原生成中的潜在机制。
我们进行了详细的临床、放射学和分子表型分析,此外,还对患者培养的成纤维细胞中的胶原进行了分析,并进行了电子显微镜检查。
迄今为止报道的患者的临床表型似乎一致,但有趣的是,似乎也存在明确的表型线索(管状骨骨干干骺端皱折性骨折伴干骺端硬化,这些发现OI 中不常见)与潜在基因型(变体)相关。
(脯氨酰 4-羟化酶,β亚基)编码 PDI(蛋白二硫键异构酶),在细胞中,以四聚体形式催化胶原中 4-羟脯氨酸的形成。. 中的反复出现的变体 c.1178A>G,p.Tyr393Cys,位于 C 末端反应中心,据说是干扰 C 末端反应中心的二硫键异构酶功能。P4HB 催化前胶原螺旋域中 X-Pro-Gly 重复序列中脯氨酸残基的羟化。鉴于细胞外基质(ECM)成分在功能性基质组装中的相互依赖性,我们的数据表明,受干扰的是功能性 ECM 的组织和组装,而不是 I 型胶原本身的分泌。
我们提供了. 是一种特定形式的 OI-CCS 的原因的额外证据,并扩展了在这种罕见疾病中双膦酸盐治疗反应的信息。